Status:
COMPLETED
Ablating Atrial Tachycardias Occuring During Ablation of Complex Fractionated Electrograms in Persistent AF
Lead Sponsor:
Deutsches Herzzentrum Muenchen
Collaborating Sponsors:
Klinik für Kardiologie, Klinikum Karlsruhe, Prof. Dr. C. Schmitt
Conditions:
Atrial Fibrillation
Ablation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Catheter ablation has proven to be an effective treatment option in patients suffering from symptomatic persistent atrial fibrillation (AF). Catheter ablation consists of two major steps: (1) Isolatio...
Eligibility Criteria
Inclusion
- Patients (\>=18 und \< 80 years) with symptomatic persistent AF (AF episode enduring at least 7 days) but are successfully convertable in sinus rhythm (SR).
- At least one unsuccessful attempt of antiarrhythmic drug (betablocker or class I oder III).
- Oral anticoagulation with phenprocoumone or warfarine for at least 4 weeks prior to ablation with weekly documented INR \> 2..
- Withdrawal of antiarrhythmic drugs at least 3 half times prior to ablation except amiodarone.
- Atrial tachycardia occurring during ablation of CFAE (defined as CL \> 200 msec und stable activation sequence).
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2014
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT01229033
Start Date
January 1 2010
End Date
January 1 2014
Last Update
April 11 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Karlsruhe
Karlsruhe, Germany, 76133
2
Deutsches Herzzentrum München
München, Germany, 80636